NAD+ for Mitochondrial Disease

NAD+ IV Therapy Infusion Treatment for Mitochondrial Disease

The powerhouses of each cell, mitochondria process oxygen and convert nutrients into fuel for biological functions. Genetic disorders known as mitochondrial diseases, which can be present from birth but can also develop at any age, interfere with the body’s ability to produce energy. These conditions can affect almost any part of the body and can be challenging to diagnose. Because there is no known cure, treatments typically consist of supportive therapy.

Clinical studies indicate that a coenzyme the human body produces, nicotinamide adenine dinucleotide (NAD+), is present in declining levels as the body ages. This coenzyme is responsible for converting nutrients into adenosine triphosphate as part of the mechanism by which mitochondria power cells. It also supports mitochondrial health and may provide patients living with mitochondrial disease relief from some symptoms.

How NAD+ IV Therapy Can Help Those with Mitochondrial Disease

The aging process is linked with a natural decline in levels of nicotinamide adenine dinucleotide, but reduced NAD+ levels are also associated with mitochondrial dysfunction. Restoring healthy levels of nicotinamide adenine dinucleotide can be challenging with oral supplements, as absorption through the gastrointestinal tract is less efficient. NAD+ IV therapy, on the other hand, administers therapeutic treatment directly into the bloodstream for greater bioavailability.

SkinRx IV Bar, takes a personalized approach to NAD+ IV therapy for mitochondrial disease. We take the individual needs of your unique body and symptoms into consideration. Our care team, overseen by a qualified Pharmacist, administers a tailored blend of NAD+ coenzyme, anti-nausea agents and Glutathione for deep detoxification and mood stabilization. Cells are renewed, inflammation is reduced and your body is left feeling a deeper sense of wellness with increased mental clarity.

Contact us today to find out more about this exciting NAD+ IV therapy for mitochondrial disease.

error: Content is protected !!